NASDAQ:PHIO

Phio Pharmaceuticals Shares Tick Higher as CEO Hits the Road; Traders Eye Small Biotech
····

Phio Pharmaceuticals Shares Tick Higher as CEO Hits the Road; Traders Eye Small Biotech

Phio Pharmaceuticals shares rose 1.39% to $1.095 Wednesday as the company prepared to present its PH-762 skin-cancer program at a virtual investor event. CEO Robert Bitterman will discuss the INTASYL platform and Phase 1b results, which showed a 65% response rate among cutaneous squamous cell carcinoma patients. Phio plans to seek FDA feedback on its next trial design in Q2 2026. Market cap stood near $12.55 million.
May 27, 2026

Stock Market Today

  • Clean Power Hydrogen Surges as Potential Penny Stock Winner in Renewable Energy
    May 27, 2026, 1:34 PM EDT. Clean Power Hydrogen (LSE: CPH2), a UK-based green hydrogen technology firm, has seen its market capitalization more than double to £66 million this year, driven by its innovative Membrane-Free Electrolyser (MFE) technology. The MFE produces clean hydrogen and oxygen simultaneously without costly membranes, reducing breakdowns and maintenance. While shares have risen 169% since May 2023, they remain down 77.2% over five years. The company targets sectors like healthcare, life sciences, mobility, and data centers, where hydrogen can improve efficiency. Despite uncertainties around US tariffs and global conflicts, Clean Power Hydrogen's recent deal with BKW/Abe and industry interest highlight potential growth amid shifting hydrogen market dynamics noted by Wood Mackenzie. Investors should weigh this volatility before buying.